- Home
- KRMD vs SENS Comparison
KRMD vs SENS Comparison
Compare KRMD & SENS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KRMD | SENS |
|---|---|---|
| Founded | 1980 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 198.3M | 308.5M |
| IPO Year | 2019 | 2014 |
Fundamental Metrics
Financial Performance| Metric | KRMD | SENS |
|---|---|---|
| Price | $4.40 | $6.60 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 5 |
| Target Price | $6.50 | ★ $22.70 |
| AVG Volume (30 Days) | 143.0K | ★ 509.2K |
| Earning Date | 03-12-2026 | 03-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 53.85 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $41,127,366.00 | $16,389,000.00 |
| Revenue This Year | $20.32 | $70.20 |
| Revenue Next Year | $17.38 | $59.10 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 22.23 | 19.85 |
| 52 Week Low | $1.87 | $0.41 |
| 52 Week High | $6.61 | $8.75 |
Technical Indicators
Market Signals| Indicator | KRMD | SENS |
|---|---|---|
| Relative Strength Index (RSI) | 40.44 | 46.46 |
| Support Level | $4.31 | $5.41 |
| Resistance Level | $5.12 | $6.87 |
| Average True Range (ATR) | 0.20 | 0.39 |
| MACD | 0.02 | 0.07 |
| Stochastic Oscillator | 46.30 | 73.78 |
Price Performance
Historical ComparisonAbout KRMD KORU Medical Systems Inc. (DE)
KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).
About SENS Senseonics Holdings Inc.
Senseonics Holdings Inc is a medical technology company. It is focused on the design, development, and commercialization of glucose monitoring system, which helps people to manage their diabetes community with differentiated, long-term implantable glucose management technology. Its products and services include a Continuous glucose monitoring system, Sensor, Smart transmitter, and Mobile app. The firm has a Glucose monitoring product segment. The majority of the revenue is generated outside of the United States.